Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer

Overview of attention for article published in Nature Medicine, July 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

So far, Altmetric has seen 95 news stories from 67 outlets.

Abstract Background Gastric cancer (GC) ranks fifth for morbidity and third for mortality worldwide.

ABSTRACT PURPOSE. To assess the ability of circulating tumor DNA (ctDNA)-based testing to identify patients with HER2 (encoded…

Guardant Health Expands Guardant360 ® Portfolio With New Tests for Treatment Response Monitoring and Complete Genomic Profiling…

New Guardant360 Response™ blood test predicts treatment response to immunotherapy and targeted therapy, up to eight weeks…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 91 additional news stories.